Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of pelvic radiotherapy with cisplatin with or without cetuximab in cervical cancer
2008-001053-18Phase 2Active
- Sponsor
- Institut Curie
- Start
- Apr 2008
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab, cisplatin in Cervical Cancer (CC), sponsored by Institut Curie. Started Apr 2008; status: active.
02
Drugs
cetuximabcisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2008-001053-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001053-18.